These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7594330)
1. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Shimoyama T J Clin Gastroenterol; 1995; 20 Suppl 2():S132-5. PubMed ID: 7594330 [TBL] [Abstract][Full Text] [Related]
2. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer. Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322 [TBL] [Abstract][Full Text] [Related]
3. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311 [TBL] [Abstract][Full Text] [Related]
4. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930 [TBL] [Abstract][Full Text] [Related]
5. Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients. Shirai T; Takagi A; Kurumada T; Ohta U; Kobayashi H; Harasawa S; Miwa T J Clin Gastroenterol; 1995; 20 Suppl 2():S128-31. PubMed ID: 7594329 [TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients. Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of lansoprazole in eradication of Helicobacter pylori. Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori. Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324 [TBL] [Abstract][Full Text] [Related]
11. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
12. High-dose ecabet sodium improves the eradication rate of helicobacter pylori in dual therapy with lansoprazole and amoxicillin. Kagaya H; Kato M; Komatsu Y; Mizushima T; Sukegawa M; Nishikawa K; Hokari K; Takeda H; Sugiyama T; Asaka M Aliment Pharmacol Ther; 2000 Nov; 14(11):1523-7. PubMed ID: 11069325 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing. Nakata H; Itoh H; Nishioka S J Clin Gastroenterol; 1995; 20 Suppl 2():S118-20. PubMed ID: 7594326 [TBL] [Abstract][Full Text] [Related]
14. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India. Bhasin DK; Sharma BC; Ray P; Pathak CM; Singh K Helicobacter; 2000 Jun; 5(2):84-7. PubMed ID: 10849056 [TBL] [Abstract][Full Text] [Related]
15. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Isomoto H; Inoue K; Furusu H; Nishiyama H; Shikuwa S; Omagari K; Mizuta Y; Murase K; Murata I; Kohno S Helicobacter; 2003 Apr; 8(2):111-9. PubMed ID: 12662378 [TBL] [Abstract][Full Text] [Related]
16. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
17. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [TBL] [Abstract][Full Text] [Related]
18. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy. Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen. Adachi K; Ishihara S; Hashimoto T; Hirakawa K; Ishimura N; Niigaki M; Kaji T; Kawamura A; Sato H; Fujishiro H; Hattori S; Watanabe M; Kinoshita Y Aliment Pharmacol Ther; 2001 Aug; 15(8):1187-91. PubMed ID: 11472321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]